EUVIMEDEUVIMED entdecken
Crossref

Enhancing Fractionated Cancer Therapy: A Triple-Anthracene Photosensitizer Unleashes Long-Persistent Photodynamic and Luminous Efficacy

Youjuan Wang, Hengxin Shen, Zhe Li, Shiyi Liao, Baoli Yin, Renye Yue, Guoqiang Guan, Baode Chen, Guosheng Song iD

Journal of the American Chemical Society · 06.03.2024 · 146 (9) · 6252-6265

DOI: 10.1021/jacs.3c14387 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 20.02.2024. Verfasst von Youjuan Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Chemo/Bio-Sensing and Chemometrics, College of Chemistry and Chemical Engineering, Hunan University, Changsha 410082, P. R. …. Hauptthemen laut MEDLINE: Photochemotherapy, Neoplasms. Die Arbeit wurde bisher 106-mal zitiert (Crossref) und nennt 86 Literaturangaben. Gefördert von: National Key Research and Development Program of China, China Postdoctoral Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Conventional photodynamic therapy (PDT) is often limited in treating solid tumors due to hypoxic conditions that impede the generation of reactive oxygen species (ROS), which are critical for therapeutic efficacy. To address this issue, a fractionated PDT protocol has been suggested, wherein light irradiation is administered in stages separated by dark intervals to permit oxygen recovery during these breaks. However, the current photosensitizers used in fractionated PDT are incapable of sustaining ROS production during the dark intervals, leading to suboptimal therapeutic outcomes (Table S1). To circumvent this drawback, we have synthesized a novel photosensitizer based on a triple-anthracene derivative that is designed for prolonged ROS generation, even after the cessation of light exposure. Our study reveals a unique photodynamic action of these derivatives, facilitating the direct and effective disruption of biomolecules and significantly improving the efficacy of fractionated PDT (Table S2). Moreover, the existing photosensitizers lack imaging capabilities for monitoring, which constraints the fine-tuning of irradiation parameters (Table S1). Our triple-anthracene derivative also serves as an afterglow imaging agent, emitting sustained luminescence postirradiation. This imaging function allows for the precise optimization of intervals between PDT sessions and aids in determining the timing for subsequent irradiation, thus enabling meticulous control over therapy parameters. Utilizing our novel triple-anthracene photosensitizer, we have formulated a fractionated PDT regimen that effectively eliminates orthotopic pancreatic tumors. This investigation highlights the promise of employing long-persistent photodynamic activity in advanced fractionated PDT approaches to overcome the current limitations of PDT in solid tumor treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhotochemotherapyNeoplasmsPhotosensitizing AgentsReactive Oxygen SpeciesAnthracenesCell Line, Tumor

Substanzen

Photosensitizing AgentsReactive Oxygen SpeciesanthraceneAnthracenes

Autor:innen und Institutionen

  • State Key Laboratory for Chemo/Bio-Sensing and Chemometrics, College of Chemistry and Chemical Engineering, Hunan University, Changsha 410082, P. R. China.

ORCID-Profile: Guosheng Song

Förderung

  • National Key Research and Development Program of China
  • China Postdoctoral Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Wang, Y., Shen, H., Li, Z., Liao, S., Yin, B., Yue, R., Guan, G., Chen, B., & Song, G. (2024). Enhancing Fractionated Cancer Therapy: A Triple-Anthracene Photosensitizer Unleashes Long-Persistent Photodynamic and Luminous Efficacy. Journal of the American Chemical Society, 146(9), 6252-6265. https://doi.org/10.1021/jacs.3c14387

Vancouver

Wang Y, Shen H, Li Z, Liao S, Yin B, Yue R, et al. Enhancing Fractionated Cancer Therapy: A Triple-Anthracene Photosensitizer Unleashes Long-Persistent Photodynamic and Luminous Efficacy. Journal of the American Chemical Society. 2024;146(9):6252-6265. doi:10.1021/jacs.3c14387

BibTeX
@article{Wang2024,
  author = {Wang, Youjuan and Shen, Hengxin and Li, Zhe and Liao, Shiyi and Yin, Baoli and Yue, Renye and Guan, Guoqiang and Chen, Baode and Song, Guosheng},
  title = {Enhancing Fractionated Cancer Therapy: A Triple-Anthracene Photosensitizer Unleashes Long-Persistent Photodynamic and Luminous Efficacy},
  journal = {Journal of the American Chemical Society},
  year = {2024},
  volume = {146},
  number = {9},
  pages = {6252--6265},
  doi = {10.1021/jacs.3c14387}
}
Kostenlos starten →